Neurocrine Biosciences CFO Matt Abernethy received 5,020 shares at $0 on September 11, then forfeited 2,709 shares and sold 2,311 shares, leaving 42,808 shares after the sale. The sequence gives investors the reported award, withholding-related transaction and sale details tied to his holdings.

Key Highlights

  • Matt Abernethy forfeited 2,709 Neurocrine Biosciences shares at $156.22 per share on September 11.
  • The CFO sold 2,311 shares at $157.20 per share on September 14.
  • Abernethy held 42,808 Neurocrine Biosciences shares after the sale.

Neurocrine Biosciences Inc (NASDAQ: NBIX) awarded Chief Financial Officer Matt Abernethy 5,020 shares at $0 on September 11. The award was followed by a share forfeiture and a sale recorded in separate transactions.

CFO Share Transactions on September 11 and September 14

The September 11 forfeiture involved 2,709 shares at $156.22 per share. Abernethy held 45,119 shares after that transaction, equal to about 5.7% of his prior holding. On September 14, he sold 2,311 Neurocrine Biosciences shares at $157.20 per share and held 42,808 shares afterward, representing about 5.1% of his prior holding.

Transaction Codes and Reported Holdings

After the award, Abernethy’s reported holding was 47,828 shares, and the award represented about 10.5% of that resulting position.